135 related articles for article (PubMed ID: 21057216)
1. AMPK signaling: a targetable tumor suppressor pathway?
Schneider A; Gartenhaus RB
Cancer Biol Ther; 2010 Dec; 10(11):1178-81. PubMed ID: 21057216
[No Abstract] [Full Text] [Related]
2. AMPK as a therapeutic target in renal cell carcinoma.
Woodard J; Joshi S; Viollet B; Hay N; Platanias LC
Cancer Biol Ther; 2010 Dec; 10(11):1168-77. PubMed ID: 20948309
[TBL] [Abstract][Full Text] [Related]
3. A possible role for AMP-activated protein kinase activated by metformin and AICAR in human granulosa cells.
Kai Y; Kawano Y; Yamamoto H; Narahara H
Reprod Biol Endocrinol; 2015 Apr; 13():27. PubMed ID: 25889494
[TBL] [Abstract][Full Text] [Related]
4. Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals.
Faggi L; Giustina A; Tulipano G
Mol Cell Endocrinol; 2018 Jul; 470():60-74. PubMed ID: 28962892
[TBL] [Abstract][Full Text] [Related]
5. Metformin preconditioning protects Daphnia pulex from lethal hypoxic insult involving AMPK, HIF and mTOR signaling.
Sheng B; Liu J; Li GH
Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):51-8. PubMed ID: 22564403
[TBL] [Abstract][Full Text] [Related]
6. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
[TBL] [Abstract][Full Text] [Related]
7. Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production.
Fitzgerald JP; Nayak B; Shanmugasundaram K; Friedrichs W; Sudarshan S; Eid AA; DeNapoli T; Parekh DJ; Gorin Y; Block K
PLoS One; 2012; 7(1):e30712. PubMed ID: 22303451
[TBL] [Abstract][Full Text] [Related]
8. AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms.
Dai YL; Huang SL; Leng Y
Int J Biol Sci; 2015; 11(11):1272-80. PubMed ID: 26435693
[TBL] [Abstract][Full Text] [Related]
9. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway.
Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW
Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388
[TBL] [Abstract][Full Text] [Related]
10. AICAR-induced activation of AMPK inhibits the migration of TSCC cells by targeting ZO-1.
Guo XH; Lai XJ; Cai XL; Peng Y; Wu FH; Yin MZ; Li Y; Zhang JL; Zhao G
Oral Dis; 2020 Jan; 26(1):228-233. PubMed ID: 31604003
[No Abstract] [Full Text] [Related]
11. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
12. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
[TBL] [Abstract][Full Text] [Related]
13. Activation of the AMP-activated protein kinase reduces inflammatory nociception.
Russe OQ; Möser CV; Kynast KL; King TS; Stephan H; Geisslinger G; Niederberger E
J Pain; 2013 Nov; 14(11):1330-40. PubMed ID: 23916727
[TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3).
Nerstedt A; Johansson A; Andersson CX; Cansby E; Smith U; Mahlapuu M
Diabetologia; 2010 Nov; 53(11):2406-16. PubMed ID: 20652679
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II Modulates p130Cas of Podocytes by the Suppression of AMP-Activated Protein Kinase.
Ha TS; Park HY; Seong SB; Ahn HY
J Korean Med Sci; 2016 Apr; 31(4):535-41. PubMed ID: 27051236
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
[TBL] [Abstract][Full Text] [Related]
17. AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells.
Lv Q; Zhen Q; Liu L; Gao R; Yang S; Zhou H; Goswami R; Li Q
Life Sci; 2015 Jun; 131():23-9. PubMed ID: 25817233
[TBL] [Abstract][Full Text] [Related]
18. The Hepatic Plasma Membrane Citrate Transporter NaCT (SLC13A5) as a Molecular Target for Metformin.
Kopel J; Higuchi K; Ristic B; Sato T; Ramachandran S; Ganapathy V
Sci Rep; 2020 May; 10(1):8536. PubMed ID: 32444674
[TBL] [Abstract][Full Text] [Related]
19. Metabolic regulation of neuronal plasticity by the energy sensor AMPK.
Potter WB; O'Riordan KJ; Barnett D; Osting SM; Wagoner M; Burger C; Roopra A
PLoS One; 2010 Feb; 5(2):e8996. PubMed ID: 20126541
[TBL] [Abstract][Full Text] [Related]
20. 5'-AMP-activated protein kinase (AMPK) regulates progesterone receptor transcriptional activity in breast cancer cells.
Wu L; Huang XJ; Yang CH; Deng SS; Qian M; Zang Y; Li J
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):172-7. PubMed ID: 22093824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
